High Yield Oncogenes and Tumor Suppressor Genes Flashcards
What is the gene BCR-ABL associated with?
Function: Non-receptor tyrosine kinase
Diseases: Chronic Myeloid Leukemia (CML), translocation t(9;22)
What is the function of the BRAF gene, and which diseases are linked to it?
Function: Serine/threonine kinase
Diseases: Melanoma, Hairy cell leukemia
Which gene is involved in Polycythemia Vera and what is its function?
Gene: JAK2
Function: Non-receptor tyrosine kinase
The MYC gene is a transcription factor. What disease is it associated with?
Disease: Burkitt lymphoma, translocation t(8;14)
BCL-2 inhibits apoptosis. Which lymphoma is it linked to?
Disease: Follicular lymphoma, translocation t(14;18)
What diseases are linked to overexpression of HER2/neu?
Function: Receptor tyrosine kinase (intracellular)
Diseases: Breast cancer, Gastric cancer
CCND1 regulates which cell cycle protein and is associated with which lymphoma?
Function: Cyclin D
Disease: Mantle cell lymphoma, translocation t(11;14)
Which proto-oncogene encodes a GTPase involved in colorectal and pancreatic adenocarcinoma?
Gene: KRAS
Diseases: Colorectal adenocarcinoma, Pancreatic adenocarcinoma
What is the function of APC/β-catenin, and which conditions are associated with its mutation?
Function: Wnt signaling
Diseases: Colorectal adenocarcinoma, Familial adenomatous polyposis
BRCA1 and BRCA2 are involved in which critical cellular process? Name the related cancers.
Function: DNA repair
Diseases: Breast cancer, Ovarian cancer
TP53 is a major checkpoint regulator. What syndrome and cancers are linked to it?
Diseases: Li-Fraumeni syndrome, Various other cancers
Mutations in RB lead to which cancers? What is its cellular role?
Function: Checkpoint regulator
Diseases: Retinoblastoma, Osteosarcoma
VHL is involved in degrading hypoxia-inducible factor 1a. Which diseases are linked to it?
Diseases: Renal cell carcinoma, Von Hippel-Lindau syndrome
The WT1 gene plays a role in urogenital differentiation. Which tumor is associated with it?
Disease: Wilms tumor (Nephroblastoma)
What is the key difference in mutation requirements between proto-oncogenes and tumor suppressor genes in cancer pathogenesis?
Proto-oncogene: Requires a “1-hit” gain of function mutation to become an oncogene → ↑↑ Growth, uncontrolled proliferation
Tumor suppressor gene: Requires “2-hit” loss of function mutations → ↑↑ Growth, uncontrolled proliferation
What gene mutation is associated with Chronic Myeloid Leukemia (CML)?
BCR-ABL (Philadelphia chromosome, t(9;22))
The BCR-ABL fusion gene results in a non-receptor tyrosine kinase that drives the pathogenesis of CML.
What are the clinical features of Chronic Myeloid Leukemia (CML)?
Fatigue, night sweats, weight loss, splenomegaly, early satiety, easy bruising
These symptoms are common due to the overproduction of myeloid cells.
What is the prognosis for Chronic Myeloid Leukemia (CML) with targeted therapy?
Good with targeted therapy; risk of progression to blast crisis if untreated
Targeted therapies significantly improve the prognosis of patients with CML.
What treatment options are available for Chronic Myeloid Leukemia (CML)?
Tyrosine kinase inhibitors (TKIs) like imatinib, dasatinib, nilotinib; bone marrow transplant in resistant cases
TKIs are the first-line treatment for CML, while bone marrow transplant is considered for resistant cases.
What proto-oncogene is involved in melanoma?
BRAF (often V600E mutation)
The BRAF mutation plays a critical role in melanoma progression.
What are the symptoms of melanoma?
Asymmetrical mole with irregular borders, color variation, diameter >6mm, evolving lesion
These characteristics are part of the ABCDE criteria for melanoma detection.
How does the prognosis of melanoma depend on the depth of invasion?
Depends on depth of invasion (Breslow thickness); metastatic disease has poor prognosis without treatment
Breslow thickness is a critical factor in determining melanoma prognosis.
What treatments are available for melanoma?
Surgical excision, immune checkpoint inhibitors (nivolumab, pembrolizumab), BRAF inhibitors (vemurafenib) for advanced disease
Treatment options vary based on the stage and characteristics of the melanoma.
What gene mutation is found in Hairy Cell Leukemia?
BRAF
The BRAF mutation is a hallmark of Hairy Cell Leukemia.